文献速递心脑血管急症

T-MACS评分与TIMI评分在急诊胸痛患者中的比较

Comparison of the T-MACS score with the TIMI score in patients presenting to the emergency department with chest pain.
PubMed 文献 · Am J Emerg Med · 2022-07-16
一句话结论急诊胸痛疑似NSTEMI患者中,T-MACS评分在识别低危(极低危)、高危及预测1个月MACE方面优于TIMI评分。

本研究前瞻性评估310例急诊胸痛疑似NSTEMI患者的TIMI与T-MACS评分,主要终点为30天MACE(包括急性冠脉综合征、血运重建需求和死亡)。T-MACS极低危预测MACE的敏感性100%、NPV 100%;T-MACS高危预测MACE的敏感性60%、特异性99.66%、PPV 92.3%。TIMI低危预测MACE的敏感性35%、NPV 95.2%;TIMI高危预测MACE的敏感性10%、PPV 25%。作者认为T-MACS评分在判断低危、高危及预估1个月MACE风险方面较TIMI评分更成功。

要点

  • 310例急诊胸痛疑似NSTEMI患者中,1个月MACE率6.5%,ACS率5.5%,死亡率1.3%。
  • T-MACS极低危预测MACE:敏感性100%、特异性51.72%、PPV 12.5%、NPV 100%。
  • T-MACS高危预测MACE:敏感性60%、特异性99.66%、PPV 92.3%、NPV 97.3%。
  • TIMI低危预测MACE:敏感性35%、特异性88.97%、PPV 17.9%、NPV 95.2%。
  • TIMI高危预测MACE:敏感性10%、特异性97.93%、PPV 25%、NPV 94%。

适用人群与场景

  • 于急诊科就诊的胸痛患者,疑似NSTEMI,且符合纳入和排除标准;前瞻性评估310例。

研究设计与关键结果

  • 前瞻性研究,纳入310例急诊胸痛疑似NSTEMI患者,评估TIMI与T-MACS评分;主要终点为30天MACE,包括急性冠脉综合征、需血运重建和死亡。
  • 患者平均年龄49.7 ± 19.4岁;1个月死亡率1.3%,MACE率6.5%,ACS率5.5%。
  • T-MACS极低危风险等级预测MACE:敏感性100%、特异性51.72%、PPV 12.5%、NPV 100%。
  • TIMI低危风险等级预测MACE:敏感性35%、特异性88.97%、PPV 17.9%、NPV 95.2%。
  • T-MACS高危风险等级预测MACE:敏感性60%、特异性99.66%、PPV 92.3%、NPV 97.3%。
  • TIMI高危风险等级预测MACE:敏感性10%、特异性97.93%、PPV 25%、NPV 94%。

证据类型、等级与局限

  • 证据类型:前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于急诊胸痛患者,T-MACS评分在确定低危(T-MACS评分为极低危)、高危以及预估1个月MACE风险方面,较TIMI评分更成功。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Guidelines recommend the use of risk scoring in patients with chest pain. In this study, we aimed to compare the thrombolysis in myocardial infarction risk index (TIMI) score with the Troponin Only Manchester Acute Coronary Syndrome Score (T-MACS) score and to investigate the usability of the T-MACS score in the emergency department.

METHODS: In our study; The TIMI and T-MACS scores of 310 patients with suspected NSTEMI who applied to the emergency department with chest pain and met the inclusion and exclusion criteria were prospectively evaluated. The primary outcome was MACE at 30 days including acute coronary syndromes, need for revascularization and deaths. Descriptive data and TIMI and T-MACS scores for predicting MACE and ACS was evaluated by calculating sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). ROC (Receiver Operating Characteristic) analysis was also performed to determine TIMI and T-MACS risk class.

RESULTS: In our study, the mean age of the patients was 49.7 ± 19.4 years, the 1-month mortality rate was 1.3%, majör adverse cardiac event (MACE) rate was 6.5%, and acute coronary syndrome (ACS) rate was 5.5%. T-MACS risk class for predicting MACE sensitivity 100%, selectivity 51.72, PPV 12.5% (for very low risk), NPV was calculated as 100%; sensitivity for TIMI risk class low risk 35%, selectivity 88.97%, PPV was calculated as 17.9%, NPV was calculated as 95.2%. T-MACS high risk class for predicting MACE; sensitivity was 60%, selectivity 99.66%, PPV 92.3% and NPV was 97.3%; TIMI high risk class for predicting MACE; sensitivity was 10%, selectivity was 97.93%, PPV was 25% and NPV was 94%.

CONCLUSIONS: The findings obtained in this study suggest that the T-MACS score is more successful than the TIMI score in determining the low risk (very low risk for T-MACS score), high risk, and estimated 1-month MACE risk in cases who presented to the emergency department with chest pain.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kesgün M, Yavuz BG, Satilmis D, et al. Comparison of the T-MACS score with the TIMI score in patients presenting to the emergency department with chest pain. Am J Emerg Med. 2022. PMID: 35878571. doi:10.1016/j.ajem.2022.07.017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。